The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study

Experimental and Molecular Pathology

Volumn 82, Issue 3, 2007, Pages 280-283

  Lakoski, Susan G ^a   Li, Liwu ^b   Langefeld, Carl D ^a   Liu, Yongmei ^a   Howard, Timothy D ^a   Brosnihan, K Bridget ^a   Xu, Jianfeng ^a   Bowden, Donald W ^a   Herrington, David M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

C reactive protein; CRP; Innate immunity; Interleukin 1 receptor associated kinase 1; IRAK1

Indexed keywords

C REACTIVE PROTEIN; INSULIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1;

ADULT; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; INNATE IMMUNITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

EID: 34247591959     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.02.002     Document Type: Article

References (15)

1. Bjorkbacka H., Kunjathoor V.V., Moore K.J., Koehn S., Ordija C.M., Lee M.A., et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10 4 (2004) 416-421
2. Edfeldt K., Swedenborg J., Hansson G.K., and Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 10 (2002) 1158-1161
3. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 16 (2003) 2109-2114
4. Huang Y., Li T., Sane D.C., and Li L. IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression. J. Biol. Chem. 279 49 (2004) 51697-51703
5. Khera A., McGuire D.K., Murphy S.A., Stanek H.G., Das S.R., Vongpatanasin W., et al. Race and gender differences in C-reactive protein levels. J. Am. Coll. Cardiol. 46 3 (2005) 464-469
6. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347 3 (2002) 185-192
7. Lakoski S.G., Cushman M., Criqui M., Rundek T., Blumenthal R., D'Agostino Jr. R.B., and Herrington D.M. Gender differences and C-reactive protein: data from the Multi-Ethnic Study of Atherosclerosis (MESA). Am. Heart J. 152 (2006) 593-598
8. Medzhitov R., and Janeway Jr. C. Innate immunity. N. Engl. J. Med. 343 5 (2000) 338-344
9. Newton-Cheh C., and O'Donnell C.J. Sex differences and genetic associations with myocardial infarction. JAMA 291 24 (2004) 3008-3010
10. O'Connell J.R. Zero-recombinant haplotyping: applications to fine mapping using SNPs. Genet Epidemiol. 19 Suppl. 1 (2000) S64-S70
11. O'Connell J.R. PROFILER: a program to compute cumulative probability profiles with applications to pedigree analysis. Am. J. Hum. Genet. 67 (2000) A328
12. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 351 25 (2004) 2599-2610
13. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 12 (2000) 836-843
14. Satterthwaite G., Francis S.E., Suvarna K., Blakemore S., Ward C., Wallace D., et al. Differential gene expression in coronary arteries from patients presenting with ischemic heart disease: further evidence for the inflammatory basis of atherosclerosis. Am. Heart J. 150 3 (2005) 488-499
15. Zhang D., Sun M., Samols D., and Kushner I. STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J. Biol. Chem. 271 16 (1996) 9503-9509